Criteria Bio Ventures is a leading life sciences venture fund looking to partner with transformative companies to shape the future of healthcare.
Joined January 2024
- Tweets 18
- Following 250
- Followers 35
- Likes 16
7 Photos and videos
Pinned Tweet
16 Oct 2024
Pleased to have participated in the oversubscribed $17.2M seed financing of Tolerance Bio, a Philadelphia based #biopharma pioneering thymus-based therapies for immune-mediated diseases.
News here: tolerancebio.com/recent-news…
#portfolionews #venturecapital #biotech #immunology
1
1
223
16 Oct 2024
Pleased to have participated in the oversubscribed $17.2M seed financing of Tolerance Bio, a Philadelphia based #biopharma pioneering thymus-based therapies for immune-mediated diseases.
News here: tolerancebio.com/recent-news…
#portfolionews #venturecapital #biotech #immunology
1
1
223
16 Oct 2024
Tolerance Bio is developing an allogeneic, or “off the shelf”, thymus iPSC-based #celltherapy platform along w pharmacological thymus therapies to address immune-mediated diseases caused by abnormalities in immune tolerance like autoimmune diseases, transplant rejection & cancer
1
1
51
16 Oct 2024
Proud to welcome Tolerance Bio to our portfolio and support its innovative programs in the exciting field of thymus-based therapies!
Learn more about Tolerance Bio & this financing: tolerancebio.com/recent-news…
#portfolionews #venturecapital #lifesciences #financing #autoimmunity
1
33
9 Jul 2024
Proud sponsors one more edition of @CataloniaBioHT #BBQ2024. See you all next week at one of the best #biotech summer events in town!
9 Jul 2024
🟢 Hurry up! The #BBQ2024 is back next week and there are very few tickets available! 😎
👉 tuit.cat/ioY57
🙌 Our sponsors:
🥇/deeplabs, @leanbiopro, @GPPharm, @YsiosCapital
🥈@AsabysPartners, @Asphalion, @CriteriaBioVC , @inveready, @InvivoCapital @merckgroup
1
263
Criteria Bio Ventures retweeted
28 Jun 2024
📢Pablo Cironi (@CriteriaBioVC) resume los highlights de su intervención y el papel de Caixa Capital Risk
📍Taller 'Introducción a la Innovación y Transferencia en Biomedicina y Salud' de ASEICA-@FundlaCaixa @msmelanoma
ℹ️:aseica.es/diez-investigadore…
1
3
396
15 May 2024
We are attending @AseBio Investor Day!
A fantastic event to feel the pulse of the Spanish biotech ecosystem.
#AseBioID2024
64
8 May 2024
Next week we will be attending #BioEquityEurope 2024 in San Sebastian to meet #biotech entrepreneurs and catch up with #pharma industry leaders and fellow #venturecapital investors.
If you are also participating, get in touch with us to arrange a meet up! 🤝
334
7 May 2024
Today we attended the second edition of @CataloniaBioHT #ConnectionDay24
7 May 2024
🔛🟢 The second edition of the #ConnectionDay24 is on!
Many thanks to all attendees for your trust and for having exceeded expectations, once again, this year. Let networking and connections begin!
#WeAreCataloniaBioHT
1
37
15 Mar 2024
Next week we will be attending #BIOEuropeSpring 2024 in Barcelona to meet #biotech entrepreneurs and catch up with #pharma industry leaders and fellow #venturecapital investors.
If you are also participating, get in touch with us to arrange a meet up! 🤝
112
15 Mar 2024
Thrilled to announce the well-deserved promotions of @RubenSebas_ and Salvatore Cappadona to Senior Associates within our investment team 🚀
Their exceptional talent and invaluable contributions have been instrumental in driving our mission forward. Congrats Ruben & Salvatore!
1
537
14 Mar 2024
Today Pablo Cironi, Managing Director, and @RubenSebas_, Sr Associate, are representing @CriteriaBioVC at CNIO Investor's Day 2024.
A great event to interact with the scientists of one of the leading cancer research centers worldwide.
@CNIOStopCancer
#cancertherapy #innovation
1
1
174
8 Feb 2024
Our portfolio company @Inbiomotion and @SourceBio have signed an exclusive agreement for MAF Test® in the UK and Ireland.
The MAF Test® will benefit ~56,000 new #breastcancer patients each year.
More info 👉 inbiomotion.com/documents/24…
#CBVnews #portfolionews #oncology
ALT Inbiomotion and Source BioScience sign an exclusive agreement for MAF Test® in United Kingdom and Ireland
2
2
92
22 Jan 2024
#tbt last year we welcomed AbolerIS Pharma! We led the €27.3M Series A round of AbolerIS, a Belgian #biotech developing a novel immunotherapy for autoimmune and inflammatory diseases.
#CBVnews #portfolionews #immunology #autoimmunity #venturecapital
aboleris-pharma.com/aboleris…
99
Criteria Bio Ventures retweeted
18 Jan 2024
Meet the @CriteriaBioVC team! Stay informed about the latest news from our portfolio. Follow us on this new account for updates on our #biotech and #lifesciences investments and team activities!
@CriteriaBioVC web➡️ goo.su/N3bW2
#biotech #lifesciences #pharma
2
5
273
Criteria Bio Ventures retweeted
16 Jan 2024
We are launching new @X profiles! From today we will share our #VC activity on #Tech topics from the account @CriteriaVT. Everything related to #Biotech and #LifeSciences will be available at @CriteriaBioVC.
Follow us ⬇️!
🔬goo.su/N3bW2
🤖goo.su/m60dOF
1
4
250
16 Jan 2024
Exciting news! Our new website is live, providing a fresh look into Criteria Bio Ventures. Follow us for updates on our portfolio, team activities, and more.
Let the journey begin! 🚀
#CBVnews #venturecapital #biotech #lifesciences #pharma
criteriabioventures.com/
2
4
808